The American Diabetes Association (ADA), Boys & Girls Club of Snohomish County (BGCSC) and the Cliff Avril Family Foundation ...

Type 2 diabetes is a chronic condition where the body either doesn't produce enough insulin or doesn't use it effectively, ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

Age, race, income level, obesity, and physical inactivity all contribute to the risk of being diagnosed with diabetes.

The black marks on the neck should not be ignored, as they can be one of the earliest signs of insulin resistance and a ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Advances in AI have allowed researchers to use a short audio clip to detect diabetes with 66 percent accuracy in women and 71 ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer’s disease or Parkinson’s disease, and a 30% reduced risk ...

Combination may offer a substitute to basal-bolus insulin in people with type 2 diabetes inadequately controlled with daily basal insulin.

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.